The estimated Net Worth of Julie D Klapstein is at least $554 Тысяча dollars as of 1 April 2020. Ms. Klapstein owns over 250 units of NextGen Healthcare Inc stock worth over $191,352 and over the last 9 years she sold NXGN stock worth over $85,733. In addition, she makes $277,055 as Independent Director at NextGen Healthcare Inc.
Sign up
Ms. Klapstein NXGN stock SEC Form 4 insiders trading
Julie has made over 2 trades of the NextGen Healthcare Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 250 units of NXGN stock worth $44,660 on 1 April 2020.
The largest trade she's ever made was selling 250 units of NextGen Healthcare Inc stock on 1 April 2020 worth over $44,660. On average, Julie trades about 20 units every 4 days since 2016. As of 1 April 2020 she still owns at least 7,993 units of NextGen Healthcare Inc stock.
You can see the complete history of Ms. Klapstein stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Julie Klapstein biography
Julie D. Klapstein serves as Independent Director of the Company. She was the founding Chief Executive Officer of Availity, LLC, one of the nation’s largest health information networks optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. Ms. Klapstein served as Availity’s Chief Executive Officer and board member from 2001 to 2011. She was the interim Chief Executive Officer at Medical Reimbursements of America, Inc., a private company, from February 2017 to June 2017. Ms. Klapstein’s more than thirty years of experience in the healthcare information technology industry include executive roles at Phycom, Inc. (President and Chief Executive Officer from 1996 to 2001), Sunquest Information Systems (Executive Vice President), Shared Medical Systems’ Turnkey Systems Division (now Siemens Medical Systems), and GTE Health Systems. Ms. Klapstein is a director of Amedisys Inc., a public company, since April 2016, where she serves on the Governance and Quality committees, and where she is chair of the Compensation committee. She also currently serves on the board of directors for two private companies, eSolutions, Inc., which specializes in revenue cycle management solutions, and Revecore, which specializes in underpayments and denials for hospitals. Ms. Klapstein previously was a director for two public companies, Annie’s Homegrown/Annies, Inc. from January 2012 to September 2014, where she served on the Governance, Compensation, and Audit committees, and Standard Register Inc. from April 2011 to November 2014, where she served on the Governance, Compensation, and Audit committees. She also has been a director for multiple private companies. Ms. Klapstein earned her bachelor’s degree from Portland State University in Portland, Oregon.
What is the salary of Julie Klapstein?
As the Independent Director of NextGen Healthcare Inc, the total compensation of Julie Klapstein at NextGen Healthcare Inc is $277,055. There are 14 executives at NextGen Healthcare Inc getting paid more, with John Frantz having the highest compensation of $6,306,870.
How old is Julie Klapstein?
Julie Klapstein is 65, she's been the Independent Director of NextGen Healthcare Inc since 2017. There are 3 older and 14 younger executives at NextGen Healthcare Inc. The oldest executive at NextGen Healthcare Inc is Sheldon Razin, 82, who is the Chairman Emeritus and Independent Director.
What's Julie Klapstein's mailing address?
Julie's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Insiders trading at NextGen Healthcare Inc
Over the last 6 years, insiders at NextGen Healthcare Inc have traded over $7,074,219 worth of NextGen Healthcare Inc stock and bought 30,075 units worth $371,046 . The most active insiders traders include David William Sides, Lance Rosenzweig и David A Metcalfe. On average, NextGen Healthcare Inc executives and independent directors trade stock every 28 days with the average trade being worth of $352,900. The most recent stock trade was executed by Mitchell Waters on 22 September 2023, trading 5,452 units of NXGN stock currently worth $130,521.
What does NextGen Healthcare Inc do?
nextgen healthcare information systems, llc, a wholly owned subsidiary of quality systems, inc., provides integrated clinical, financial, and connectivity solutions for primary care physicians, specialist physicians, health systems, and dental provider organizations. the company drives collaborative care and patient engagement with a comprehensive suite of products and services that support emerging initiatives such as patient-centered medical home, accountable care organizations, and health information exchange.
What does NextGen Healthcare Inc's logo look like?
Complete history of Ms. Klapstein stock trades at Amedisys, NextGen Healthcare Inc и Oak Street Health
NextGen Healthcare Inc executives and stock owners
NextGen Healthcare Inc executives and other stock owners filed with the SEC include:
-
John Frantz,
President, Chief Executive Officer, Director -
James Arnold,
Chief Financial Officer, Executive Vice President -
David Metcalfe,
Executive Vice President, Chief Technology Officer -
Jeffrey Linton,
Executive Vice President, General Counsel, Secretary -
Srinivas S. Velamoor,
Exec. VP, Chief Growth & Strategy Officer -
James Robert Arnold Jr.,
Exec. VP & CFO -
David A. Metcalfe,
Exec. VP & CTO -
Mitchell L. Waters,
Exec. VP of Commercial Growth -
Jeffrey D. Linton,
Exec. VP, Gen. Counsel & Sec. -
Craig Barbarosh,
Independent Vice Chairman of the Board -
Sheldon Razin,
Chairman Emeritus and Independent Director -
Jeffrey Margolis,
Independent Chairman of the Board -
George Bristol,
Independent Director -
James Malone,
Independent Director -
Morris Panner,
Independent Director -
Julie Klapstein,
Independent Director -
Lance Rosenzweig,
Independent Director -
David Ahmadzai,
Senior Vice President, Principal Accounting Officer, Corporate Controller -
Donna Cullen Greene,
Exec. VP of HR -
Colleen Edwards,
Sr. VP of Marketing -
Matthew Scalo,
VP of Investor Relations -
David Slazyk,
Chief Information & Security Officer -
David William Sides,
CEO, Pres & Director -
Dr. Martin Lustick,
Principal & Sr. VP -
Graham Brown,
Principal & Sr. VP -
Dr. Betty Rabinowitz,
Chief Medical Officer -
John S. Beck,
Chief Solutions Officer & Exec. VP -
Donna Greene,
Sr. VP of HR -
Darnell Dent,
-
Pamela Puryear,
-
Srinivas S Velamoor,
See Remarks -
Mitchell Waters,
EVP, Commercial Growth -
Donna Cullen Greene,
EVP, Human Resources -
Geraldine Mc Ginty,
-
Lonnie Allen Plunk,
EVP, Operations -
David William Sides,
President and CEO